Amarantus Bioscience Holdings Inc (OTCQB:AMBS)

0.0795
Delayed Data
As of 10:08am ET
 0.00005 / +0.06%
Today’s Change
0.05
Today|||52-Week Range
0.20
-3.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$63.5M

Company Description

Amarantus Bioscience Holdings, Inc. is a development stage biotechnology company, which engages in discovering and developing treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. It develops and owns intellectual property and proprietary technology to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
--
-- California --
P:
Investor Relations:

Employees

Shareholders

Individual stakeholders4.88%
Mutual fund holders--
Other institutional--

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account